SEC Filing Summary: Oculus Innovative Sciences, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. on February 4, 2016. The report serves to announce the financial results for the fiscal quarter ended December 31, 2015. The full details of these results are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
The filing does not explicitly state material changes versus the prior comparable period within the body of the 8-K. Investors must refer to the attached press release for comparative financial data.
Guidance, Outlook, and Risks
The report contains forward-looking statements regarding the company's intentions, beliefs, expectations, and strategies. Management notes that these statements involve risks, uncertainties, and assumptions that could cause actual results to differ materially from expectations. Specific risks are referenced as being discussed in the company's Annual Report on Form 10-K and other SEC filings. The company undertakes no obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended December 31, 2015, by reviewing Exhibit 99.1 (Press Release).
- Confirm the company's cash position and liquidity status as detailed in the attached press release.
- Review the Form 10-K for a comprehensive list of risk factors referenced in this filing.
- Note that the registrant name in the filing is Oculus Innovative Sciences, Inc., distinct from the "Sonoma Pharmaceuticals, Inc." mentioned in the request metadata.